Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study
Sign Up to like & getrecommendations! Published in 2017 at "Gynecological Endocrinology"
DOI: 10.1080/09513590.2017.1320377
Abstract: Abstract This observational study compares the ratio of serum anti-Mullerian hormone (AMH) to the total antral follicle count (AFC) (as a marker of AMH production per follicle) in the various phenotypes of women with polycystic… read more here.
Keywords: pcos; amh production; pcom; amh ... See more keywords
Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome
Sign Up to like & getrecommendations! Published in 2017 at "Human Reproduction"
DOI: 10.1093/humrep/dex239
Abstract: STUDY QUESTION Does the use of the serum anti-Müllerian hormone (AMH) assay to replace or complement ultrasound (U/S) affect the diagnosis or phenotypic distribution of polycystic ovary syndrome (PCOS)? SUMMARY ANSWER Combining U/S and the… read more here.
Keywords: classification; diagnosis; pcom; phenotypic ... See more keywords
109 What mattersto me?: development and use of a person centred outcome measure (pcom) for parents of children with feeding disorders
Sign Up to like & getrecommendations! Published in 2017 at "Archives of Disease in Childhood"
DOI: 10.1136/archdischild-2017-084620.81
Abstract: Background NHS England's Five Year Forward View sets out how the health service needs to change, arguing for "a more engaged relationship with patients, carers and citizens so that we can promote wellbeing and prevent… read more here.
Keywords: project; use; pcom; person ... See more keywords